| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $199.1B | $177.0B | $171.3B | $156.6B | $138.6B | $31.8B | $27.4B | $23.4B |
| Cost of Revenue | $21.2B | $19.8B | $17.3B | $13.0B | $10.9B | $9.0B | $2.0B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $21.0B | $20.0B | $20.1B | $17.7B | $15.9B | $17.4B | $13.4B | $14.0B |
| Operating Income | $7.2B | $7.9B | $8.5B | $8.5B | $7.5B | $6.4B | $6.0B | $5.4B |
| Net Income | $5.7B | $6.0B | $6.0B | $6.0B | $6.1B | $0.6B | $0.9B | $0.4B |
| EPS (Basic) | $25.28 | $25.81 | $25.38 | $25.10 | $25.04 | $2.23 | $3.69 | $1.64 |
| EPS (Diluted) | $25.21 | $25.68 | $25.22 | $24.81 | $24.73 | $2.19 | $3.62 | $1.61 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $121.5B | $116.9B | $108.9B | $102.8B | $97.5B | $86.6B | $77.5B | $71.6B |
| Current Assets | $63.0B | $58.9B | $60.0B | $55.6B | $51.1B | $45.8B | $39.0B | $34.3B |
| Cash & Equivalents | $9.5B | $8.3B | $6.5B | $7.4B | $4.9B | $5.7B | $4.9B | $3.9B |
| Total Liabilities | $77.5B | $75.5B | $69.5B | $66.4B | $61.3B | $53.4B | $45.7B | $43.0B |
| Current Liabilities | $41.0B | $40.6B | $41.8B | $39.7B | $34.9B | $29.5B | $23.6B | $22.0B |
| Stockholders' Equity | $43.9B | $41.3B | $39.3B | $36.3B | $36.1B | $33.2B | $31.7B | $28.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.3B | $5.8B | $8.1B | $8.4B | $8.4B | $10.7B | $6.1B | $3.8B |
| Investing Cash Flow | $-1.3B | $-5.2B | $-5.6B | $-4.6B | $-9.6B | $-7.3B | $-2.8B | $-1.3B |
| Capital Expenditures | $1.1B | $1.3B | $1.3B | $1.2B | $1.1B | $1.0B | $1.1B | $1.2B |
| Financing Cash Flow | $-1.7B | $1.2B | $-3.3B | $-1.3B | $0.4B | $-2.6B | $-2.3B | $-2.2B |